Psoriasis Patients' Tolerance for Therapeutic Risks in Return for Symptom Improvement in the United Kingdom

Juan Marcos Gonzalez; Juan Marcos Gonzalez; F Reed Johnson; F Mughal

Psoriasis Patients' Tolerance for Therapeutic Risks in Return for Symptom Improvement in the United Kingdom

Gonzalez, J., Johnson, F., & Mughal, F. (2013). Psoriasis Patients' Tolerance for Therapeutic Risks in Return for Symptom Improvement in the United Kingdom. Value in Health, 16(7), A508-A508.

Copy citation

Recent Publications

Article

Treatment preferences among patients with mild-to-moderate atopic dermatitis

December 31, 2023

Article

Understanding how infection prevention influences nurses' task sequencing using a mixed-methods, simulation-based approach

December 01, 2023

Article

Consensus-based framework for evaluating data modernization initiatives

October 01, 2023

Article

∆8-THC-COOH cross-reactivity with cannabinoid immunoassay kits and interference in chromatographic testing methods

September 15, 2023

View All Publications